[Visual loss after pars plana vitrectomy with membrane peeling]

Ophthalmologe. 2013 Dec;110(12):1192-6. doi: 10.1007/s00347-013-2880-4.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Blindness / diagnosis
  • Blindness / etiology*
  • Blindness / prevention & control*
  • Epiretinal Membrane / surgery*
  • Female
  • Humans
  • Middle Aged
  • Retinal Detachment / diagnosis
  • Retinal Detachment / etiology*
  • Retinal Detachment / therapy*
  • Treatment Outcome
  • Vitrectomy / adverse effects*

Substances

  • Antibodies, Monoclonal, Humanized
  • Bevacizumab